Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) has issued an update.
ASKA Pharmaceutical Holdings Co., Ltd. reported its consolidated financial results for the second quarter of FY2025, showing a year-on-year increase in net sales by 8.9% to 35,253 million yen. However, the company experienced a decline in operating profit by 20.8% and a decrease in profit attributable to owners of the parent by 13.0%. The company has revised its forecast for the full fiscal year, expecting a 10.7% increase in net sales and a 12.5% rise in operating profit, indicating a cautious yet optimistic outlook for the remainder of the fiscal year.
The most recent analyst rating on (JP:4886) stock is a Hold with a Yen2305.00 price target. To see the full list of analyst forecasts on ASKA Pharmaceutical Holdings Co., Ltd. stock, see the JP:4886 Stock Forecast page.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. is a company listed on the Tokyo Stock Exchange, primarily engaged in the pharmaceutical industry. The company focuses on the development, manufacturing, and marketing of pharmaceutical products, with a market emphasis on innovative healthcare solutions.
Average Trading Volume: 75,832
Technical Sentiment Signal: Sell
Current Market Cap: Yen55.73B
See more data about 4886 stock on TipRanks’ Stock Analysis page.